Ignite Creation Date:
2024-05-19 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06420076
Status:
RECRUITING
Last Update Posted:
2024-05-17
First Post:
2024-05-14
Brief Title:
Sequential CAR-T Cells Therapy for CD5CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5CD7-Specific CAR-T Cells
Sponsor:
Essen Biotech
Organization:
Essen Biotech
Organization Data
Organization:
Essen Biotech
Class:
OTHER
Study ID:
ESBI202496
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Essen Biotech
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None